Will Gilead ' s Big Veklury Beat Offset A Cancer Drug Miss?

Gilead beat first-quarter calls, but it came on the back of Covid drug Veklury. And Gilead stock could take hit Thursday. The post Will Gilead's Big Veklury Beat Offset A Cancer Drug Miss? appeared first on Investor's Business Daily.#gilead #veklury #willgilead
Source: Reuters: Health - Category: Consumer Health News Source Type: news